SETDB1 and endometrial carcinoma: Additionally, the SETDB1 mutation frequency in patients with mixed endometrial carcinomas was the highest (15.09% of 517 cases), including 8.51% (44 cases) mutation and 6.58% (34 cases) amplification (Figure 8(b)).